mRNA Vaccine and Therapeutics Market 2021-26: Industry Growth, Size, Share, Analysis and Forecast

SHERIDAN, Wyo. - Aug. 22, 2021 - PRLog -- According to IMARC Group's latest report, the global mRNA vaccines and therapeutics market potential is expected to reach a value of US$ 9.41 Billion in 2021. Looking forward, the market is projected to register a CAGR of 10.5% during 2021-2026, reaching a value of US$ 15.49 Billion by 2026.

The messenger ribonucleic acid, or mRNA, refers to a protein-coding gene in the genome that provides a basis for protein synthesis within the cells. The mRNA vaccines and therapeutics include self-amplifying, in-vivo self-replicating, and in-vitro dendritic cell non-replicating mRNA that combine the desirable immunological properties. These vaccines are usually injected into the body to trigger virus-detecting immune sensors and produce viral antigen protein cells, which aid in enhancing the immunity of the body by improving B- and T- cell responses.

Market Trends

The mRNA vaccines are more effective against pathogens, cost-efficient, and have enhanced immunogenicity and higher potency. As a result, leading players are focusing on the development of an mRNA-based vaccine for the coronavirus disease (COVID-19). The success of the vaccine for COVID-19 can potentially boost the market growth. Along with this, improvements in healthcare technologies, such as the development of lipid nanoparticle formulations for in-vivo systemic delivery of mRNA, is providing a positive impact on the industry.

Request Free Sample Report:

List of Key Companies Covered in this Market Report:
  • Argos Therapeutics Inc. (SCM Life Science and Genexine)
  • AstraZeneca
  • Bayer AG
  • BioNTech AG
  • Boehringer Ingelheim
  • CRISPR Therapeutics
  • CureVac AG
  • eTheRNA Immunotherapies
  • Ethris GmbH
  • In-Cell-Art
  • Intellia Therapeutics Inc.
  • Moderna Therapeutics
  • Sangamo Therapeutics
  • Tiba Biotech LLC
  • Translate Bio Inc.
Ask Analyst and Browse Full Report with TOC & List of Figure:

The report has segmented the market on the basis of vaccine type, treatment type, vaccine manufacturing, application, end-user and geography.

Breakup by Vaccine Type:
  • Self-amplifying mRNA-based Vaccines
  • Conventional Non-Amplifying mRNA-Based Vaccines
  • Others

Breakup by Treatment Type:
  • Bioengineered Vaccine Based Treatment
  • Gene Therapy (Gene Silencing/Suppression)
  • Gene Transcription (Protein Generation)
  • Cell Therapy
  • Monoclonal Antibody Based Treatment
  • Others

Breakup by Vaccine Manufacturing:
  • In-House mRNA Vaccine Manufacturing
  • Out-Sourced mRNA Vaccine Manufacturing

Breakup by Application:
  • Cancer
  • Infectious Disease
  • Vaccines In-vivo Therapeutics
  • Gene Editing
  • Others

Breakup by End-User:
  • Hospitals and Clinics
  • Research Organizations
  • Others
Contact US:

30 N Gould St, Ste R
Sheridan, WY 82801, USA
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

Posted By:*** Email Verified
Tags:mRNA Vaccine
Location:Sheridan - Wyoming - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Trending News
Most Viewed
Top Daily News

Like PRLog?
Click to Share